- Tuebingen, Germany
- On-site
- Contract · Staff
Combine experimental immunopeptidomics, quantitative proteomics and data interpretation to characterize HLA-presented targets, advance our platform toward future clinical applications and contribute to our mission of delivering novel PRAME immunotherapies to patients with cancer.
Responsibilities
- Characterize and quantify HLA-presented peptides using Immatics’ proprietary absolute quantitation technology to support therapeutic target validation and the evaluation of biomarkers for patient selection and disease monitoring.
- Develop, optimize and validate immunopeptidomics methodologies using protein biochemistry and mass spectrometry, with a focus on reproducibility, scalability and the analysis of clinically relevant samples.
- Coordinate and manage target characterization activities across departments, aligning experimental plans, timelines and interpretation of results with laboratory, mass spectrometry and Data Intelligence colleagues.
- Establish suitable controls and performance criteria for new workflows, critically evaluate experimental results and document methods and findings to support their transfer into standardized laboratory processes.
- Help develop streamlined, digitally connected workflows and evaluate AI-assisted approaches to data interpretation, documentation and process improvement in collaboration with laboratory and Data Intelligence colleagues.
Requirements
- PhD in Life Sciences
- PhD in Biochemistry
- PhD in Biotechnology